Advertisement

Topics

Stealth BioTherapeutics Company Profile

18:49 EST 14th December 2018 | BioPortfolio

Stealth BioTherapeutics is a privately-held biopharmaceutical company committed to bringing mitochondria-targeted therapeutics to patients to treat both common and rare diseases. As the key common element in a variety of serious, debilitating diseases, mitochondria - the cell’s energy source - offer a promising yet untapped therapeutic target for diseases with significant unmet treatment needs. Stealth is developing its lead compounds Bendavia™ and Ocuvia™ in multiple therapeutic areas, including cardio-renal diseases, ophthalmic disorders and orphan mitochondrial diseases, and defining the broad potential of mitochondria-targeted therapies. Stealth’s promising pipeline of preclinical and clinical compounds is supported by more than 100 independent, peer-reviewed publications, abstracts and presentations.


News Articles [267 Associated News Articles listed on BioPortfolio]

Stealth BioTherapeutics Granted Fast Track Designation for Elamipretide for the Treatment of Dry Age-Related Macular Degeneration with Geographic Atrophy

BOSTON – December 10, 2018 – Stealth BioTherapeutics (Stealth), a clinical-stage biopharmaceutical company developing therapeutics to treat mitochondrial dysfunction, today announced that ...

Stealth Bio Raises $100 Million from China Investors for Mitochondrial Candidates

Stealth Biotherapeutics, a Boston a clinical-stage biopharma that targets mitochondrial dysfunction, completed a $100 million financing in two convertible note rounds led by Nan Fung Technology's Pivo...

Note rounds nab $100M for Stealth

Stealth BioTherapeutics intends to use the $100 million raised from two convertible note rounds to launch a Phase IIb study o -More- 

Evotec tapped for preclinical studies of BioTherapeutics’ lead pipeline candidate

Evotec is conducting preclinical and toxicology/safety studies for Stealth BioTherapeuticsâ lead candidate, ahead of clinical trials slated to begin in 2019.

Two US Biopharmas -- Stealth and AOBiome -- File for IPOs on Hong Kong Exchange

Two young Boston-area biotechs have filed with the Hong Kong Exchange to conduct IPOs on the exchange, taking advantage of the new rules allowing pre-revenue companies to list and seeking the high val...

#jobs #lifescience Stealth Biotech: Chief Scientific Officer

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Stealth Biotech: Chief Scientific Officer . Competitive: Stealth Biotech: Our...

Cardiovascular Systems’ Stealth 360 Peripheral OAS comes to Hong Kong

The company said that its Stealth 360 peripheral OAS was used to treat a patient in Hong Kong, which marks the first commercial use of the product outside The post Cardiovascular Systems’ Steal...

Evotec tapped for preclinical studies of StealthBioTherapeutics’ additional pipeline candidate

Evotec is conducting preclinical and toxicology/safety studies for Stealth BioTherapeuticsâ lead candidate, ahead of clinical trials slated to begin in 2019.

Drugs and Medications [14 Associated Drugs and Medications listed on BioPortfolio]

Plasmanate [TALECRIS BIOTHERAPEUTICS, INC.]

Plasma Protein Fraction (Human) 5%, USPPlasmanate®

Gamastan s/d [TALECRIS BIOTHERAPEUTICS, INC.]

Immune Globulin (Human)GamaSTAN™ S/DSolvent/Detergent Treated

Plasbumin [TALECRIS BIOTHERAPEUTICS, INC.]

Albumin (Human) 5%, USPPlasbumin ®-5

Plasbumin [TALECRIS BIOTHERAPEUTICS, INC.]

Albumin (Human) 5%, USPPlasbumin ®-5

Plasbumin [TALECRIS BIOTHERAPEUTICS, INC.]

Albumin (Human) 20%, USPPlasbumin®-20

PubMed Articles [46 Associated PubMed Articles listed on BioPortfolio]

Synthetic Biology and Engineered Live Biotherapeutics: Toward Increasing System Complexity.

Recent advances in synthetic biology and biological system engineering have allowed the design and construction of engineered live biotherapeutics targeting a range of human clinical applications. In ...

Cell Penetration Profiling Using the Chloroalkane Penetration Assay.

Biotherapeutics are a promising class of molecules in drug discovery, but they are often limited to extracellular targets due to their poor cell penetration. High-throughput cell penetration assays ar...

Live bacterial biotherapeutics in the clinic.

Data-independent oxonium ion profiling of multi-glycosylated biotherapeutics.

The characterization of glycosylation is required for many protein therapeutics. The emergence of antibody and antibody-like molecules with multiple glycan attachment sites has rendered glycan analysi...

Recent advancements, challenges, and practical considerations in the mass spectrometry-based analytics of protein biotherapeutics: A viewpoint from the biosimilar industry.

The extensive analytical characterization of protein biotherapeutics, especially of biosimilars, is a critical part of the product development and registration. High-resolution mass spectrometry becam...

Clinical Trials [12 Associated Clinical Trials listed on BioPortfolio]

A Study to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneous Injections of Elamipretide (MTP-131) in Subjects With Genetically Confirmed Mitochondrial Disease Previously Treated in the Stealth BioTherapeutics SPIMM-201 Study

This is a Phase 2, randomized, double-blind, placebo-controlled crossover study which will enroll up to 36 subjects (anticipated) with genetically confirmed mitochondrial disease who have ...

Use of Stealth Liposomal Doxorubicin HCl ( DOX-SL ) in the Treatment of Moderate to Severe AIDS-Related Kaposi's Sarcoma.

To provide Stealth liposomal doxorubicin hydrochloride ( DOX-SL ) as a therapy for Kaposi's sarcoma patients who have no remaining treatment options other than DOX-SL or patients who have ...

Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma

To determine the efficacy of Stealth liposomal doxorubicin hydrochloride (DOX-SL) in the treatment of moderate to severe AIDS-related Kaposi's sarcoma (KS) by comparison with the establish...

External Ventricular Drain Placement Stealth Study

External ventricular drain (EVD) placement is performed very often in neurosurgical practices. EVD's are most commonly placed at the bedside using external anatomical landmarks to guide th...

Neoadjuvant Chemotherapy With a Combination of Pegylated Liposomal Doxorubicin (Caelyx®) and Paclitaxel in Breast Cancer

In this study, PLD, an anthracycline encapsulated in stealth liposomes, which are believed to efficiently deliver the doxorubicin within the tumour mass with less toxicity compared with st...

Companies [114 Associated Companies listed on BioPortfolio]

Stealth BioTherapeutics

Stealth BioTherapeutics is a privately-held biopharmaceutical company committed to bringing mitochondria-targeted therapeutics to patients to treat both common and rare diseases. ...

Stealth Therapeutics Inc.

Stealth Therapeutics was founded in 2006 for the purpose of designing and developing a portfolio of improved venous access devices. The technology is derived from the clinical pra...

Axial Biotherapeutics

Axial Biotherapeutics is a biopharmaceutical company harnessing the link between the human gut microbiome and the central nervous system to develop a new class of biotherapeutics ...

Project Stealth

Napro Biotherapeutics Incorporated

NaPro BioTherapeutics, Inc. is a natural product pharmaceutical company focused primarily on the development, manufacture and commercializa tion of paclitaxel, a naturally-occurring anti-cancer agent ...

More Information about "Stealth BioTherapeutics" on BioPortfolio

We have published hundreds of Stealth BioTherapeutics news stories on BioPortfolio along with dozens of Stealth BioTherapeutics Clinical Trials and PubMed Articles about Stealth BioTherapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Stealth BioTherapeutics Companies in our database. You can also find out about relevant Stealth BioTherapeutics Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...


Corporate Database Quicklinks



Searches Linking to this Company Record